TEVA PHARMACEUTICAL INDS LTD (TEVA) — Hedge Fund Ownership Q4 2025
TEVA
- TEVA PHARMACEUTICAL INDS LTD (TEVA) is held by 3 of 82 tracked hedge funds, with Duquesne Family Office (4%) and Sound Shore Management (4%) holding the largest stakes, indicating limited hedge fund interest relative to peers.
- The biggest decreases in TEVA holdings came from Duquesne Family Office (-65%) and Sound Shore Management (-24%), suggesting profit-taking or de-risking.
- 2 hedge funds exited TEVA, led by Maverick Capital (1%).
- Overall, hedge funds decreased exposure to TEVA PHARMACEUTICAL INDS LTD (TEVA) by -60% vs the prior quarter and -36% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Duquesne Family Office
|
4.34% | 5.9M | -64.60% | -34.70% | $183.4M | $31.21 | — |
| 2 |
Sound Shore Management Harry Burn
|
4.28% | 4.3M | -23.68% | -9.70% | $134.5M | $31.21 | — |
| 3 |
DME Capital Management / Greenlight Capital
|
3.35% | 3.1M | -19.05% | +552.81% | $95.5M | $31.21 | — |
| — |
Maverick Capital Lee Ainslie
|
— | — | EXITED | — | — | — | — |
| — |
Viking Global Investors Andreas Halvorsen
|
— | — | EXITED | — | — | — | — |
| 3 | Total | — | 13.2M | -59.69% | -36.20% | $413.3M | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.